The global HIV vaccine enterprise

International Microbiology

Volumn 8, Issue 2, 2005, Pages 93-101

  Esparza, José ^a  

^a BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

AIDS; Epidemiology; HIV vaccine; Scientific enterprise

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 24944555670     PISSN: 11396709     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Barabási AL (2005) Network theory - the emergence of the creative enterprise. Science 308:639-641
2. Barre-Sinoussi F, Chermann J-C, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Brun-Vezinet F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-871
3. Braun MM, Heyward WL, Curran JW (1990) The global epidemiology of HIV infection and aids. Ann Rev Microbiol 44:555-577
4. Bush, V. (1945) Science - the endless frontier. United States Government Printing Office, Washington, DC
5. Centers for Disease Control (1981) Kaposi's sarcoma and Pneumocystis pneumonia among homosexual menNew York City and California. MMWR Morb Mortal Wkly Rep 30:305-308
6. Centers for Disease Control (1982) Epidemiologic aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections. New Engl J Med 306:248-252.
7. Cohen J (2003) AIDS vaccine still alive as booster after second failure in Thailand. Science 302:1309-1310
8. Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise (2005) The Global HIV/AIDS Vaccine Enterprise: Scientific strategic plan. PloS Med 2:e25 (Available at http://www.plosmedicine.org)
9. De Solla Price D (1963) Litle science big science. Columbia University Press, New York.
10. Desrosiers RC (2004) Prospects for an AIDS vaccine. Nature Med 10:221-223
11. Esparza J, Osmanov S (1983) HIV vaccines: a global perspective. Curr Mol Med 3:183-193.
12. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, et al (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500-503
13. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, Saxon A (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305:1425-1431
14. Klausner RD et al. (2003) The need for a global HIV vaccine enterprise. Science 300:2036-2039
15. Krim M, Ward DE (1999) The emergence and early years of the HIV/AIDS epidemic. In: Ward DE, The AmFAR AIDS handbook: The complete guide to understanding HIV and AIDS. WW Norton, New York, Chapter 20
16. Kuhn TS (1962) The structure of scientific revolutions. Univ Chicago Press, Chicago
17. Morel CM (2003) Neglected diseases: under-funded research and inadequate health interventions. EMBO Reports 4 (special issue):535-538
18. Stokes D (1997) Pasteur's quadrant: Basic science and technological innovation. Brooking Institution Press, Washington DC
19. Stover J et al. (2002) Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet 360:73-77
20. Zachary GP (1999) Endless frontier: Vannevar Bush, engineer of the American century. MIT Press, Cambridge